Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Staloral 300R SLIT in Elderly Patients with Allergic Rhinitis
NCT01605760Phase 4Completed
- Sponsor
- Medical University of Silesia
- Start
- Jan 2008
- Primary completion
- Jan 2012
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in allergic rhinitis (AR) comparing Staloral 300R with Placebo (2 arms). Primary endpoint: Number of participants with adverse event during immunotherapy at 3 years. Started Jan 2008; status: completed.
02
Drugs
dermatophagoides pteronyssinus extract
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01605760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01605760.